Found 6 matching trials
Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.
PHASE2Colonic microbiota changes may play a key role in the pathogenesis of acute...
Location
Hôpital Avicenne Service Gastro-entérologie
Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea
PHASE2Rosacea is a common chronic inflammatory relapsing-remitting skin condition...
Location
Dermatology Research Ventures
A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention
PHASE2Crohn's Disease (CD) is a chronic pathology characterized by exacerbations ...
Location
Humanitas Clinical Research Center
Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test
PHASE2Preliminary evidence suggests that treatment with rifaximin may be benefici...
Location
Ospedali Riuniti di Ancona
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
PHASE3The primary objective is to determine the efficacy of rifaximin DR also ref...
Location
Multiple Locations
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
PHASE3The primary objective is to determine the efficacy of rifaximin DR also ref...
Location
Multiple Locations